The deal combines the maker of Huggies diapers with the owner of the painkiller brand.

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, ...

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, ...

No deal might be the best outcome for dividend-seeking investors. It’s a story as old as time. Two Dividend Aristocrats meet, ...

Kimberly-Clark is buying the parent company of Tylenol, Kenvue, in a cash and stock deal worth about $48.7 billion. The deal ...

Investors will eye earnings, PMIs and a private-sector jobs gauge this week. Follow along for live news and analysis of the Dow, S&P 500 and Nasdaq.

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Kimberly Clark buy Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal expected to close in late 2026.

A silky mom is a modern mother who prefers to use any available medical, technological, or scientific advances to make ...

The consumer health and wellness giants are both Dividend Kings, with more than 50 years of consecutive annual payout ...

Nvidia and other technology stocks are propping up Wall Street. The S&P 500 was virtually unchanged Monday, even though the ...